title: Serologic identification of hepatitis E virus infections in epidemic and endemic settings.
abstract: Recombinant chimeric protein C2 containing the N-terminal region of trpE (37 kilodaltons [kDa]) and the C-terminal half (46.8 kDa) of the polypeptide encoded by ORF2 of the hepatitis E virus (HEV) genome was used for the construction of a Western blot diagnostic test for IgG and IgM antibodies to the virus (anti-HEV). (The C2 protein and the trpE protein devoid of C2 activity and used as a control for non-specific reactions were purified by recovery from sodium dodecyl sulfate-polyacrylamide gel electrophoresis [SDS-PAGE] and used for preparation of strips). Specificity of the test was proven with sera obtained from patients with acute hepatitis non-A, non-B, non-C (NANBNC) from outbreaks in different geographic regions of the world. IgG antibodies reactive to the recombinant C2 protein were detected in 93% of patients with acute hepatitis NANBNC and remained detectable in 89-100% of these patients 1-24 months after onset of jaundice. IgM antibodies were detected in 73% of patients within 26 days after onset of jaundice, in 50% 1-4 months after onset, in 6% 6-7 months after onset, and in no patients by 8 months after onset. When this test was used to identify sporadic hepatitis E cases in different regions of the world, such cases were found almost exclusively in areas where outbreaks of the disease had occurred and rarely in any other regions.
authors.affiliation: Clinical and Diagnostic Department, D.I. Ivanofsky Institute (World Health Organization Collaborating Centre for Research and Reference on Viral Hepatitis), Academy of Medical Sciences, Moscow, USSR.
authors.forename: M O
authors.initials: MO
authors.lastname: Favorov
authors.forename: H A
authors.initials: HA
authors.lastname: Fields
authors.forename: M A
authors.initials: MA
authors.lastname: Purdy
authors.forename: T L
authors.initials: TL
authors.lastname: Yashina
authors.forename: A G
authors.initials: AG
authors.lastname: Aleksandrov
authors.forename: M J
authors.initials: MJ
authors.lastname: Alter
authors.forename: D M
authors.initials: DM
authors.lastname: Yarasheva
authors.forename: D W
authors.initials: DW
authors.lastname: Bradley
authors.forename: H S
authors.initials: HS
authors.lastname: Margolis
mesh_terms: D000293:Adolescent; D000328:Adult; D015153:Blotting, Western; D002648:Child; D002675:Child, Preschool; D004196:Disease Outbreaks; D006508:Hepatitis Antibodies / Q000097:blood; D016751:Hepatitis E / Q000453:epidemiology*; D016752:Hepatitis E virus / Q000145:classification / Q000276:immunology*; D006801:Humans; D007074:Immunoglobulin G / Q000097:blood; D007075:Immunoglobulin M / Q000097:blood; D008875:Middle Aged; D015995:Prevalence; D011994:Recombinant Proteins / Q000276:immunology; D016036:Seroepidemiologic Studies
chemical_list: D006508:Hepatitis Antibodies; D007074:Immunoglobulin G; D007075:Immunoglobulin M; D011994:Recombinant Proteins